Meta‐analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
- 1 July 1999
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 56 (2) , 131-141
- https://doi.org/10.1023/a:1006250213357
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogensBritish Journal of Cancer, 1997
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Use of tamoxifen for breast cancer: twenty-eight years later.Journal of Clinical Oncology, 1995
- Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In VitroJNCI Journal of the National Cancer Institute, 1993
- Agonistic and Antagonistic Effects of Antiestrogens in Different Target OrgansActa Oncologica, 1992
- Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the ratJournal of Steroid Biochemistry, 1990
- Prospects for Antiestrogen Chemoprevention of Breast CancerJNCI Journal of the National Cancer Institute, 1990
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- Nonsteroidal antiestrogens: Their biological effects and potential mechanisms of actionJournal of Toxicology and Environmental Health, 1978